* a base prospectus relating to the resale by certain legacy shareholders of the Company of up to 52,886,962 Ordinary Shares as well as to the primary issuance of up to 9,268,131 Ordinary Shares upon exercise of the company’s public warrants, which such securities were previously included on the Company’s registration statement on Form F-1 (File No. 333-262681) originally filed on February 11, 2022, and
* a base prospectus relating to the resale of up to 1,534,410 warrants held by certain lenders (or their affiliates) of the Company as well as to up to 3,736,935 Ordinary Shares issued or issuable upon exercise of such warrants, which such prospectus was filed to replace part of the prospectus contained in the registration statement on Form F-1 (File No. 333-268037) filed by the Company on October 28, 2022 relating to the same securities (such Form F-1 was never declared effective and the Company has since requested its withdrawal).
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM